The Scope E-Newsletter September 2009

The Scope: September 2009

From the Dean's Office

Our Mission in Focus

In the Spotlight

Researchers Granted Patent for Amyloidosis Diagnosis and Treatment

Regal Foundation Supports Pulmonary Disease Fellowship

Carlson Chairs OMFS Residency Review Committee

Solomon, Wall Lead Innovative Clinical Trial to Image Amyloidosis

Medical Student Rotations on the Rise at GSM

Wall Receives Grant to Improve Alzheimer's Diagnoses

Nelson, Mancini Perform No-Scar Surgery

Lewis Introduces Surgical Technique, Saves Limbs

Celebrate Medical Librarians Month and 20 Years of CAPHIS in October

New Faculty and Staff

News

Frontiers Magazine Features Innovations in Surgery

Continuing Medical and Dental Education

CMDE Calendar

Spaces Filling for Stroke Symposium in October

Psychiatric Symposium Changes Dates to October 29-30

Mark Your Calendar: Hematology Conference Set for January 23, 2010

Record-Breaking Attendance at Heart, Lung, Vascular Conference

Research

Graduate School of Medicine Shares Knowledge Worldwide

Presentations

Publications

 

Read all articles in this issue of The Scope

Lewis Introduces Surgical Technique, Saves Limbs

James Lewis, MD

James Lewis, MD, Assistant Professor, Surgery Division of Surgical Oncology, came to the Graduate School of Medicine in September 2008, introducing a surgical procedure known as isolated limb infusion (ILI) that has made an impression at the medical center and beyond.

The groundbreaking procedure is a minimally invasive catheter-based surgical technique used to control and, at times, cure advanced melanoma or soft tissue sarcoma of the extremity. During the procedure, high doses of chemotherapy medications are injected into an artery or vein within the affected limb while blood flow is temporarily blocked with a tourniquet. This allows large doses of chemotherapy to be administered to the limb without affecting the rest of the body. Using ILI, Dr. Lewis is able to save limbs from amputation.

"It's a standard of therapy," Dr. Lewis said, "but it's just not that common around the country. We're the first to do it in Tennessee."

Dr. Lewis performed the first ILI procedure in January, and to date, two patients have benefited from its success with a third surgery completed last week. ILI is reported to cause significant shrinkage in tumors in approximately two-thirds of patients. Results may be seen as early as two weeks with continued response for three to six months.

See news coverage of the ILI procedure on WBIR-TV 10.

Submit News to GSM